M Ventures
m-ventures.com Direct investor
M Ventures is the strategic corporate venture capital fund of Merck, investing in biotechnology and technology companies. It focuses on healthcare drug development, life science tools, electronics, and frontier technology & sustainability.
M Ventures is a corporate venture arm headquartered in Amsterdam, Netherlands, founded in 2009. It invests directly in companies, in biotechnology and technology. €600m under management and 100 portfolio companies, as it reports.
“M Ventures is the strategic, corporate venture capital fund of Merck, investing in Biotechnology and Technology.”
— M Ventures, own website
- Layer
- Direct investor
- Stage
- Unknown
- Headquarters
- Amsterdam, Netherlands
- Sectors
- Biotechnology, Technology
- Founded
- 2009
- Assets under management
- €600m
- Portfolio
- 100 companies
Team, as M Ventures publishes it
- Hakan Goker Managing Director
- Javier Rodriguez Head Technology Investments
- Caroline Soulard Chief Financial Officer
- Ebru Uzun Head of Business Operations
- Bauke Anninga Executive Director
- Christian Patze Executive Director
- Christian Uhrich Executive Director
- Noga Yerushalmi Investment Director
- Oliver Hardick Investment Director
- Sebastian Schöfer Investment Director
- Vijay Narasimhan Director of Technology Investments and Partnerships
- Emma Johnson Senior Principal
Names and roles exactly as listed on m-ventures.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 108 co-investors found.
- Sofinnova 7 shared companies: artiospharma.com, asceneuron.com, discopharma.de, dnascript.com…
- Illumina Ventures 3 shared companies: dnascript.co, lightcast.bio, ribometrix.com
- Cambium Capital Management LP 3 shared companies: seeqc.com, pacificlightandhologram.com, polariseo.com
- IP Group plc 2 shared companies: artiospharma.com, stormtherapeutics.com
- Novartis Venture Fund 2 shared companies: artiospharma.com, forxtherapeutics.com
- TCG Crossover Management, LLC 2 shared companies: artiospharma.com, plexium.com
- Kurma Partners 2 shared companies: asceneuron.com, dnascript.com
- INKEF Capital 2 shared companies: anavotx.com, ionctura.com
- VI Partners 2 shared companies: ionctura.com, altoida.com
- eCAPITAL entrepreneurial Partners 2 shared companies: beeoled.com, ferroelectric-memory.com
and 98 more — the graph.
Where this comes from
Every fact above was read from a page M Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.m-ventures.com/name, is_investor, layer, type, hq_country, hq_city, sectors, thesis_quote, thesis_quote_page, description, founded, aum, portfolio_count, status
- https://www.m-ventures.com/teampeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 1202 · added 2026-08-28 · link last verified 2026-09-06 · confidence high
Similar investors
- KPN VenturesCorporate venture · Series A – Series C+ · Rotterdam, Netherlands
- Prosus VenturesCorporate venture · Amsterdam, Netherlands
- Damen Maritime VenturesCorporate venture · Pre-seed – Series A · Netherlands
- Eneco VenturesCorporate venture · Seed – Series B · Netherlands
- ING VenturesCorporate venture · Growth – Buyout · Netherlands
- Philips VenturesCorporate venture · Seed – Growth · Netherlands